Latest / Bloomberg Law / U.S. Regulators Approve Bayer-Monsanto Tie-Up
Transcript
- 0:03Speaker 1: Welcome to the Bloomberg Law Podcast. I'm June Grosso. Every
- 0:07Speaker 1: day we bring you insight and analysis into the most
- 0:10Speaker 1: important legal news of the day. You can find more
- 0:13Speaker 1: episodes of the Bloomberg Law Podcast on Apple Podcasts, SoundCloud
- 0:18Speaker 1: and on Bloomberg dot com slash podcasts. Buyer has won
- 0:22Speaker 1: antitrust approval from the US for its sixty six billion
- 0:25Speaker 1: dollar acquisition of mont Santo, removing the last regulatory hurdle
- 0:29Speaker 1: standing in the way of what will be the world's
- 0:31Speaker 1: biggest seed in agricultural chemicals company. Speaking with Bloomberg earlier
- 0:35Speaker 1: this month, Buyer CEO Werner Bauman was confident that regulator
- 0:39Speaker 1: negotiations in the US and Europe would conclude soon. We
- 0:44Speaker 1: announced another sale of anti trust assets to BSF and
- 0:50Speaker 1: with it, I can confirm that we continue to be
- 0:53Speaker 1: very confident, actually very confident that we are going to
- 0:56Speaker 1: close this transaction in quarter too. Joining us in our
- 1:00Speaker 1: New York studios is Jennifer Ree, Bloomberg Intelligence senior litigation analysts.
- 1:05Speaker 1: Jen what did Buyer have to give up to win
- 1:08Speaker 1: approval from the US Justice Department, Well, they had to
- 1:11Speaker 1: give up a lot. I mean, in this case, they're
- 1:13Speaker 1: selling nine billion dollars worth of assets to be a
- 1:16Speaker 1: s F. All of it's going to be a s F,
- 1:19Speaker 1: which is really pretty huge in terms of a divestiture
- 1:22Speaker 1: package to get a deal through. I mean maybe compared
- 1:24Speaker 1: to sixty six billion, which is what we see the
- 1:26Speaker 1: deal is valued at it it doesn't seem so, but
- 1:29Speaker 1: but it really is very, very big. And this is
- 1:32Speaker 1: EU and US because a lot of the same assets
- 1:35Speaker 1: were required to be sold by both jurisdictions with I
- 1:38Speaker 1: think a few differences at the fringes but um and
- 1:42Speaker 1: if you added on by the US. But this is really,
- 1:44Speaker 1: you know, a very large package and including lots of seeds,
- 1:47Speaker 1: lots of traits, lots of R and D, as well
- 1:51Speaker 1: as crop protection. So jen there have been several deals
- 1:57Speaker 1: as we've talked about involving seed and crop chemical firms globally.
- 2:01Speaker 1: This deal will leave three mega companies and farmers are
- 2:05Speaker 1: concerned about higher prices and less choice. Does it seem
- 2:09Speaker 1: as if they have a point? Certainly with the less
- 2:10Speaker 1: choice they're cutting it down, Well, you know, I think so.
- 2:13Speaker 1: But the reason for these divestitures and part of the
- 2:16Speaker 1: reason this is such a huge package all going to
- 2:18Speaker 1: one entity B A s F is that the idea
- 2:21Speaker 1: is that the depart that that remedy is meant to
- 2:24Speaker 1: remedy the harm that could occur. And so at the
- 2:27Speaker 1: end of the day, you don't really have three big
- 2:29Speaker 1: integrated agricultural entities left. You really have four, because what
- 2:32Speaker 1: you're doing is you're turning B A. S F into
- 2:34Speaker 1: an entity that's very similar to Dowdy Pont, to Kemp,
- 2:37Speaker 1: China's and Genta and now to Buyer Montsanto. They were
- 2:40Speaker 1: very active on the chemical side, and the crop protection
- 2:43Speaker 1: side didn't it didn't have seats. But they're now buying
- 2:45Speaker 1: a very very large package of seeds as well as
- 2:48Speaker 1: R and D from Buyer to put them in place
- 2:50Speaker 1: to compete with the other three entities. And that's the
- 2:53Speaker 1: purpose of a remedy. Now, so does the merger of
- 2:57Speaker 1: Buyer and Montsant Monsanto makes send Now with all the
- 3:01Speaker 1: things that's had to do to satisfy regulators, well, the
- 3:04Speaker 1: synergies and the competitive advantages still be there, I think. So,
- 3:09Speaker 1: you know, obviously, if they didn't think at this stage
- 3:11Speaker 1: that what they're being asked to divest, you know, kills
- 3:14Speaker 1: their efficiencies and the synergies that they would have gained,
- 3:17Speaker 1: they likely wouldn't go forward with the deal, you know,
- 3:19Speaker 1: they would have abandoned it. I think months ago when
- 3:22Speaker 1: they began to understand exactly what it was going to
- 3:24Speaker 1: take to try to get this get this through. And
- 3:26Speaker 1: you know, even though they're selling a lot of buyers seeds,
- 3:30Speaker 1: you know, they are still getting this combination of Buyers
- 3:33Speaker 1: chemicals with Monsanto seats, which is really what they wanted,
- 3:37Speaker 1: Monsanto having the bigger heritage and the seeds and Buyer
- 3:40Speaker 1: having the bigger heritage on the chemical side. So it
- 3:42Speaker 1: took about two years for the seal to go through
- 3:45Speaker 1: almost So what does it signal about the Justice Department
- 3:49Speaker 1: and its antitrust stanced if anything, that they're willing to
- 3:53Speaker 1: work with companies or go to court. Has we've seen
- 3:56Speaker 1: an A T and T time Warner. I you know,
- 3:58Speaker 1: I don't think it's signal very much. Some of these
- 4:01Speaker 1: really big and complicated deals have been taking a long time.
- 4:04Speaker 1: This was about twenty one months, but remember it was
- 4:07Speaker 1: well underway before the new head of the Antitrust Division
- 4:10Speaker 1: at the Department of Justice stepped into his position. Um.
- 4:14Speaker 1: I think one of the things though, it shows is
- 4:16Speaker 1: that he is standing by some of the statements he
- 4:18Speaker 1: made earlier this year that he doesn't really believe in
- 4:20Speaker 1: what we call conductor behavioral remedies because here he saw
- 4:24Speaker 1: some vertical concerns, and it has been historically the practice
- 4:27Speaker 1: to remedy a vertical problem with the behavioral with a
- 4:30Speaker 1: behavioral remedy rather than asset sales. And here this is
- 4:34Speaker 1: all asset sales. And so he's showing that he he
- 4:37Speaker 1: means what he says when he says he doesn't like
- 4:39Speaker 1: the option of a behavioral remedy because he doesn't want
- 4:42Speaker 1: to have to keep the track. Can we discern any
- 4:47Speaker 1: clues on what this may mean for future deals such
- 4:52Speaker 1: a you know that need government approval like uh Sprint
- 4:55Speaker 1: and T Mobile. Well, it shows that they're going to
- 4:58Speaker 1: vigorously investigate these deals and and where they truly have concerns,
- 5:01Speaker 1: they're going to require assets to be sold in order
- 5:03Speaker 1: to remedy those concerns. I think I think that that
- 5:06Speaker 1: deal in particular will will have a tough time, and
- 5:09Speaker 1: I'm not so sure that they're going to be able
- 5:10Speaker 1: to get get it cleared. They're going to have to
- 5:12Speaker 1: convince them that what they're going to be able to
- 5:14Speaker 1: innovate in five g is sort of outweighs the anti
- 5:18Speaker 1: competitive effect. Let's say that you might get from reducing
- 5:21Speaker 1: from four big competitors to three in that market, And
- 5:24Speaker 1: I think that might be a tough argument, and I
- 5:26Speaker 1: do think they're going to face a pretty tough investigation.
- 5:30Speaker 1: Jen what other pending deals are looking pretty iffy because
- 5:35Speaker 1: of the Justice Department's tough stance. Well, you know, it's
- 5:38Speaker 1: really hard to understand what's going to happen going forward
- 5:41Speaker 1: with some of these deals that are really just vertical
- 5:43Speaker 1: in nature, like CBS is deal um expressed express scripts.
- 5:48Speaker 1: It's hard to say that with sign you know, because
- 5:51Speaker 1: like I said, historically these deals have had some very
- 5:55Speaker 1: nice pro competitive aspects to them because it's a vertical
- 5:58Speaker 1: integration rather than a deal where a competitors being taken
- 6:01Speaker 1: out of the market um, And they have historically been
- 6:04Speaker 1: remedied by these behavioral conditions, which I think are more
- 6:07Speaker 1: palatable in for these companies in a vertical deal than
- 6:10Speaker 1: selling off assets. And it's hard to understand what will
- 6:14Speaker 1: happen with those going those sorts of deals going forward
- 6:17Speaker 1: if in fact, behavioral remedies are off the table. For
- 6:20Speaker 1: this Department of Justice. And let's turn to a big
- 6:24Speaker 1: date coming up. That is the decision by the judge
- 6:28Speaker 1: in the A. T and T Time Warner case. Tell
- 6:31Speaker 1: us about that, well, we expect that on June twelfth,
- 6:34Speaker 1: which is sort of a nice treat for the judge
- 6:35Speaker 1: to tell everybody, Okay, June twelfth is the day I'm
- 6:38Speaker 1: coming out of this big decision. It's a lot of
- 6:40Speaker 1: pressure and I think there's gonna be a lot of
- 6:42Speaker 1: news media descending on the courthouse on that day because
- 6:44Speaker 1: we don't always know when these decisions are going to
- 6:47Speaker 1: get publicized. Um, it'll be interesting to see. I suspect
- 6:50Speaker 1: that if the Department of Justice loses that case, it's
- 6:53Speaker 1: likely that they will appeal, um and to keep the
- 6:55Speaker 1: companies from closing, they're going to have to seek an
- 6:57Speaker 1: emergency injunction just to keep them apart. Are pending the appeal,
- 7:01Speaker 1: and it's it's if he has to whether they'll win
- 7:03Speaker 1: that or not. So even if an appeal goes forward,
- 7:05Speaker 1: it's possible the companies may still be able to close
- 7:07Speaker 1: if they win. And we do want to hit this
- 7:11Speaker 1: breaking news that the ABC television network has canceled the
- 7:15Speaker 1: Rosanne Show. You know that they brought it back, but
- 7:18Speaker 1: we wanted to mention that because you know, the show
- 7:21Speaker 1: was right. Yeah, and well it was. There was a
- 7:24Speaker 1: little controversy surround. There was a little controversy surround, a
- 7:27Speaker 1: little off topic, I know, but that's a breaking news story. No,
- 7:30Speaker 1: it's it's it's very interesting. Jen, we're talking. We can
- 7:33Speaker 1: discuss about ABC, but we don't have time. We can
- 7:36Speaker 1: discuss about what's happening with that with all the media
- 7:39Speaker 1: um mergers that are afoot. Thanks so much, Jim. That's
- 7:43Speaker 1: Bloomberg Intelligence Senior litigation analyst Jennifer Ree. Thanks for listening
- 7:47Speaker 1: to the Bloomberg Law Podcast. You can subscribe and listen
- 7:51Speaker 1: to the show on Apple podcast, SoundCloud, and on Bloomberg
- 7:54Speaker 1: dot com slash podcast. I'm June Basso. This is Bloomberg,
- 8:00Speaker 1: The Gut, the Junta du Contation.